Literature DB >> 8814460

Inhibition by hydroxyachillin, sesquiterpene lactone from Tanacetum microphyllum, of PMA-induced mouse ear oedema.

A M Silván1, M J Abad, P Bermejo, A Villar.   

Abstract

4-beta-phorbol 12-myristate 13-acetate (PMA), when administered topically to mouse ear, induces a pronounced inflammatory response mediated by protein kinase C (PKC). Activation of PKC is implicated in the pathogenesis of inflammation, with phospholipase A2-dependent arachidonic acid release and eicosanoid production. We have investigated the effects of hydroxyachillin, a sesquiterpene lactone from Tanacetum microphyllum DC., on mouse ear oedema induced by PMA. The effects of this compound on swelling and other inflammatory parameters are described. Hydroxyachillin significantly (p < or = 0.01) inhibited ear swelling in a dose-dependent manner, and was as effective as the reference drugs. The PMA-induced vascular permeability was significantly (p < or = 0.05) reduced by hydroxyachillin at the highest dose (3 mg/ear). Histologically, the signs of inflammation were greatly reduced in the hydroxyachillin-treated ear lesions. These data suggest that hydroxyachillin is an effective anti-inflammatory agent in this model, and that the inhibition of PKC may be one of the mechanisms of hydroxyachillin's effect.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8814460     DOI: 10.1007/bf02280993

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  18 in total

1.  Studies and prospectives of the protein kinase c family for cellular regulation.

Authors:  Y Nishizuka
Journal:  Cancer       Date:  1989-05-15       Impact factor: 6.860

2.  Sangivamycin, a nucleoside analogue, is a potent inhibitor of protein kinase C.

Authors:  C R Loomis; R M Bell
Journal:  J Biol Chem       Date:  1988-02-05       Impact factor: 5.157

3.  Anti-inflammatory properties of the protein kinase C inhibitor, 3-[1-[3-(dimethylamino)propyl]-1H-indol-3-yl]-4-(1H-indol-3-yl)-1H- pyrrole-2,5-dione monohydrochloride (GF109203X) in the PMA-mouse ear edema model.

Authors:  S Kuchera; H Barth; P Jacobson; A Metz; C Schaechtele; D Schrier
Journal:  Agents Actions       Date:  1993

Review 4.  Protein kinase C: is its pivotal role in cellular activation over-stated?

Authors:  S E Wilkinson; T J Hallam
Journal:  Trends Pharmacol Sci       Date:  1994-02       Impact factor: 14.819

5.  A comparison of the effects of an extract of feverfew and parthenolide, a component of feverfew, on human platelet activity in-vitro.

Authors:  W A Groenewegen; S Heptinstall
Journal:  J Pharm Pharmacol       Date:  1990-08       Impact factor: 3.765

6.  In vivo formation of oxidized DNA bases in tumor promoter-treated mouse skin.

Authors:  H Wei; K Frenkel
Journal:  Cancer Res       Date:  1991-08-15       Impact factor: 12.701

7.  A bioassay for inhibition of serotonin release from bovine platelets.

Authors:  R J Marles; J Kaminski; J T Arnason; L Pazos-Sanou; S Heptinstall; N H Fischer; C W Crompton; D G Kindack; D V Awang
Journal:  J Nat Prod       Date:  1992-08       Impact factor: 4.050

8.  Tachyphylaxis in 12-0-tetradecanoylphorbol acetate- and arachidonic acid-induced ear edema.

Authors:  J M Young; B M Wagner; D A Spires
Journal:  J Invest Dermatol       Date:  1983-01       Impact factor: 8.551

9.  Compounds extracted from feverfew that have anti-secretory activity contain an alpha-methylene butyrolactone unit.

Authors:  W A Groenewegen; D W Knight; S Heptinstall
Journal:  J Pharm Pharmacol       Date:  1986-09       Impact factor: 3.765

10.  Modulation of mouse ear edema by cyclooxygenase and lipoxygenase inhibitors and other pharmacologic agents.

Authors:  R P Carlson; L O'Neill-Davis; J Chang; A J Lewis
Journal:  Agents Actions       Date:  1985-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.